Yumna Shabaik

Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity

N. Neamati, J. Deng, D. Pathania, 2010, PloS one.

The role of covalent dimerization on the physical and chemical stability of the EC1 domain of human E-cadherin.

Ambrish Roy, C. R. Middaugh, J. Laurence, 2009, Journal of pharmaceutical sciences.

In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment

Mitchell A Jackson, G. Waring, M. Robinson, 2022, Ophthalmology and Therapy.

Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.

N. Neamati, Li-Fan Zeng, Y. Long, 2011, Bioorganic & medicinal chemistry.

Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer Cells

N. Neamati, M. Millard, Yumna Shabaik, 2013, PloS one.

Small-molecule inhibitors of APE1 DNA repair function: an overview.

N. Neamati, S. Odde, Yumna Shabaik, 2012, Current molecular pharmacology.

Design and Synthesis of 3‐Carbamoylbenzoic Acid Derivatives as Inhibitors of Human Apurinic/Apyrimidinic Endonuclease 1 (APE1)

N. Neamati, A. Garofalo, F. Grande, 2012, ChemMedChem.